190 related articles for article (PubMed ID: 33901770)
41. Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation.
Xu X; Ren J; Ma Y; Liu H; Rong Q; Feng Y; Wang Y; Cheng Y; Ge R; Li Z; Bian J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):250-263. PubMed ID: 30734612
[TBL] [Abstract][Full Text] [Related]
42. Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme.
Hamilton MM; Mseeh F; McAfoos TJ; Leonard PG; Reyna NJ; Harris AL; Xu A; Han M; Soth MJ; Czako B; Theroff JP; Mandal PK; Burke JP; Virgin-Downey B; Petrocchi A; Pfaffinger D; Rogers NE; Parker CA; Yu SS; Jiang Y; Krapp S; Lammens A; Trevitt G; Tremblay MR; Mikule K; Wilcoxen K; Cross JB; Jones P; Marszalek JR; Lewis RT
J Med Chem; 2021 Aug; 64(15):11302-11329. PubMed ID: 34292726
[TBL] [Abstract][Full Text] [Related]
43. Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors.
Singh R; Salunke DB
Eur J Med Chem; 2021 Feb; 211():113071. PubMed ID: 33341650
[TBL] [Abstract][Full Text] [Related]
44. Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy.
Zhang Y; Hu Z; Zhang J; Ren C; Wang Y
Eur J Med Chem; 2022 Aug; 238():114524. PubMed ID: 35696861
[TBL] [Abstract][Full Text] [Related]
45. The ups, downs and new trends of IDO1 inhibitors.
Chen S; Tan J; Zhang A
Bioorg Chem; 2021 May; 110():104815. PubMed ID: 33773223
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
[TBL] [Abstract][Full Text] [Related]
47.
Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
[TBL] [Abstract][Full Text] [Related]
48. Discovery of potent IDO1 inhibitors derived from tryptophan using scaffold-hopping and structure-based design approaches.
Zou Y; Wang Y; Wang F; Luo M; Li Y; Liu W; Huang Z; Zhang Y; Guo W; Xu Q; Lai Y
Eur J Med Chem; 2017 Sep; 138():199-211. PubMed ID: 28667875
[TBL] [Abstract][Full Text] [Related]
49. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors.
Dong J; Pan X; Yang Y; Zhang G; Xiao Z; Liu Z
Eur J Med Chem; 2021 Nov; 223():113631. PubMed ID: 34147748
[TBL] [Abstract][Full Text] [Related]
51. Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors.
Meininger D; Zalameda L; Liu Y; Stepan LP; Borges L; McCarter JD; Sutherland CL
Biochim Biophys Acta; 2011 Dec; 1814(12):1947-54. PubMed ID: 21835273
[TBL] [Abstract][Full Text] [Related]
52. Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold.
Kinzel O; Steeneck C; Anderhub S; Hornberger M; Pinto S; Morschhaeuser B; Albers M; Sonnek C; Wang Y; Mallinger A; Czekańska M; Hoffmann T
Bioorg Med Chem Lett; 2021 Feb; 33():127738. PubMed ID: 33316404
[TBL] [Abstract][Full Text] [Related]
53. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
[TBL] [Abstract][Full Text] [Related]
54. Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Röhrig UF; Majjigapu SR; Chambon M; Bron S; Pilotte L; Colau D; Van den Eynde BJ; Turcatti G; Vogel P; Zoete V; Michielin O
Eur J Med Chem; 2014 Sep; 84():284-301. PubMed ID: 25036789
[TBL] [Abstract][Full Text] [Related]
55. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF
ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400
[TBL] [Abstract][Full Text] [Related]
56. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
Gao D; Li Y
Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
[TBL] [Abstract][Full Text] [Related]
57. Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*.
Ortiz-Meoz RF; Wang L; Matico R; Rutkowska-Klute A; De la Rosa M; Bedard S; Midgett R; Strohmer K; Thomson D; Zhang C; Mebrahtu M; Guss J; Totoritis R; Consler T; Campobasso N; Taylor D; Lewis T; Weaver K; Muelbaier M; Seal J; Dunham R; Kazmierski W; Favre D; Bergamini G; Shewchuk L; Rendina A; Zhang G
Chembiochem; 2021 Feb; 22(3):516-522. PubMed ID: 32974990
[TBL] [Abstract][Full Text] [Related]
58. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q
Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299
[TBL] [Abstract][Full Text] [Related]
59. The therapeutic potential of targeting tryptophan catabolism in cancer.
Opitz CA; Somarribas Patterson LF; Mohapatra SR; Dewi DL; Sadik A; Platten M; Trump S
Br J Cancer; 2020 Jan; 122(1):30-44. PubMed ID: 31819194
[TBL] [Abstract][Full Text] [Related]
60. Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Röhrig UF; Majjigapu SR; Vogel P; Reynaud A; Pojer F; Dilek N; Reichenbach P; Ascenção K; Irving M; Coukos G; Michielin O; Zoete V
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1773-1811. PubMed ID: 35758198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
